$IMDZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IMMUNE DESIGN CORP..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IMMUNE DESIGN CORP.. Get notifications about new insider transactions in IMMUNE DESIGN CORP. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 08 2018 | IMDZ | Immune Design Corp ... | Brady Stephen R | EVP, Strategy & Fin ... | Sell | S | 4.17 | 3,328 | 13,885 | 47,162 | 50.5 K to 47.2 K (-6.59 %) |
Jan 08 2018 | IMDZ | Immune Design Corp ... | Brady Stephen R | EVP, Strategy & Fin ... | Grant | A | 0.00 | 20,000 | 0 | 50,490 | 30.5 K to 50.5 K (+65.60 %) |
Jan 08 2018 | IMDZ | Immune Design Corp ... | Kelley Susan L. | Director | Option Exercise | A | 4.05 | 12,500 | 50,625 | 12,500 | |
Jan 08 2018 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Option Exercise | A | 4.05 | 12,500 | 50,625 | 12,500 | |
Jan 08 2018 | IMDZ | Immune Design Corp ... | RINGO WILLIAM R | Director | Option Exercise | A | 4.05 | 12,500 | 50,625 | 12,500 | |
Jan 08 2018 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Option Exercise | A | 4.05 | 12,500 | 50,625 | 12,500 | |
Jan 08 2018 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Option Exercise | A | 4.05 | 12,500 | 50,625 | 12,500 | |
Jan 08 2018 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Option Exercise | A | 4.05 | 12,500 | 50,625 | 12,500 | |
Jan 08 2018 | IMDZ | Immune Design Corp ... | BALTIMORE DAVID | Director | Option Exercise | A | 4.05 | 12,500 | 50,625 | 12,500 | |
Jan 08 2018 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Option Exercise | A | 4.05 | 80,000 | 324,000 | 80,000 | |
Jan 08 2018 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Sell | S | 4.17 | 1,986 | 8,282 | 37,068 | 39.1 K to 37.1 K (-5.09 %) |
Jan 08 2018 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Grant | A | 0.00 | 16,000 | 0 | 39,054 | 23.1 K to 39.1 K (+69.40 %) |
Jan 08 2018 | IMDZ | Immune Design Corp ... | Paya Carlos V | President and CEO | Option Exercise | A | 4.05 | 216,500 | 876,825 | 216,500 | |
Jan 08 2018 | IMDZ | Immune Design Corp ... | Paya Carlos V | President and CEO | Sell | S | 4.17 | 7,970 | 33,247 | 106,590 | 114.6 K to 106.6 K (-6.96 %) |
Jan 08 2018 | IMDZ | Immune Design Corp ... | Paya Carlos V | President and CEO | Grant | A | 0.00 | 46,500 | 0 | 114,560 | 68.1 K to 114.6 K (+68.32 %) |
Jan 05 2018 | IMDZ | Immune Design Corp ... | Yurasov Sergey | Sr. VP, Clinic. Dev ... | Option Exercise | A | 4.05 | 110,000 | 445,500 | 110,000 | |
Jan 05 2018 | IMDZ | Immune Design Corp ... | Yurasov Sergey | Sr. VP, Clinic. Dev ... | Sell | S | 4.17 | 675 | 2,816 | 27,325 | 28 K to 27.3 K (-2.41 %) |
Jan 05 2018 | IMDZ | Immune Design Corp ... | Yurasov Sergey | Sr. VP, Clinic. Dev ... | Grant | A | 0.00 | 22,000 | 0 | 28,000 | 6 K to 28 K (+366.67 %) |
Nov 06 2017 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Buy | P | 4.50 | 50,000 | 225,000 | 175,000 | 125 K to 175 K (+40.00 %) |
Nov 01 2017 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Buy | P | 4.58 | 25,000 | 114,375 | 75,000 | 50 K to 75 K (+50.00 %) |
Oct 31 2017 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Buy | P | 4.07 | 65,000 | 264,752 | 125,000 | 60 K to 125 K (+108.33 %) |
Oct 30 2017 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Buy | P | 4.10 | 2,681,000 | 10,992,100 | 6,642,942 | 4 M to 6.6 M (+67.67 %) |
Oct 27 2017 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Buy | P | 4.10 | 2,681,000 | 10,992,100 | 2,681,000 | 0 to 2.7 M |
Oct 26 2017 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Buy | P | 4.26 | 25,000 | 106,620 | 50,000 | 25 K to 50 K (+100.00 %) |
Aug 03 2017 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Option Exercise | M | 1.31 | 10,000 | 13,100 | 38,715 | |
Aug 03 2017 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Sell | S | 11.80 | 747 | 8,813 | 23,054 | 23.8 K to 23.1 K (-3.14 %) |
Aug 03 2017 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Sell | S | 11.40 | 9,253 | 105,523 | 23,801 | 33.1 K to 23.8 K (-27.99 %) |
Aug 03 2017 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Buy | M | 1.31 | 10,000 | 13,100 | 33,054 | 23.1 K to 33.1 K (+43.38 %) |
Jul 12 2017 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Buy | P | 9.33 | 2,000 | 18,650 | 20,000 | 18 K to 20 K (+11.11 %) |
Jul 12 2017 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Buy | P | 9.00 | 10,000 | 89,950 | 18,000 | 8 K to 18 K (+125.00 %) |
Jul 10 2017 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Buy | P | 9.15 | 4,000 | 36,600 | 8,000 | 4 K to 8 K (+100.00 %) |
Jul 10 2017 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Buy | P | 9.39 | 4,000 | 37,550 | 4,000 | 0 to 4 K |
May 22 2017 | IMDZ | Immune Design Corp ... | GUTHART LEO | 10% Owner | Buy | P | 6.14 | 5,000 | 30,700 | 3,128,239 | 3.1 M to 3.1 M (+0.16 %) |
May 22 2017 | IMDZ | Immune Design Corp ... | GUTHART LEO | 10% Owner | Buy | P | 6.05 | 1,000 | 6,050 | 3,123,239 | 3.1 M to 3.1 M (+0.03 %) |
May 22 2017 | IMDZ | Immune Design Corp ... | GUTHART LEO | 10% Owner | Buy | P | 6.06 | 6,000 | 36,360 | 3,122,239 | 3.1 M to 3.1 M (+0.19 %) |
May 22 2017 | IMDZ | Immune Design Corp ... | GUTHART LEO | 10% Owner | Buy | P | 6.07 | 13,270 | 80,549 | 3,116,239 | 3.1 M to 3.1 M (+0.43 %) |
May 22 2017 | IMDZ | Immune Design Corp ... | GUTHART LEO | 10% Owner | Buy | P | 6.12 | 4,730 | 28,948 | 3,102,969 | 3.1 M to 3.1 M (+0.15 %) |
Jan 06 2017 | IMDZ | Immune Design Corp ... | RINGO WILLIAM R | Director | Option Exercise | A | 5.60 | 10,000 | 56,000 | 10,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | ter Meulen Jan Henrik | Chief Scientific Of ... | Option Exercise | A | 5.60 | 70,000 | 392,000 | 70,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | ter Meulen Jan Henrik | Chief Scientific Of ... | Sell | S | 5.35 | 980 | 5,243 | 23,020 | 24 K to 23 K (-4.08 %) |
Jan 06 2017 | IMDZ | Immune Design Corp ... | ter Meulen Jan Henrik | Chief Scientific Of ... | Grant | A | 0.00 | 12,000 | 0 | 24,000 | 12 K to 24 K (+100.00 %) |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Option Exercise | A | 5.60 | 70,000 | 392,000 | 70,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Sell | S | 5.35 | 980 | 5,243 | 23,054 | 24 K to 23.1 K (-4.08 %) |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Grant | A | 0.00 | 12,000 | 0 | 24,034 | 12 K to 24 K (+99.72 %) |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Paya Carlos V | President and CEO | Option Exercise | A | 5.60 | 175,000 | 980,000 | 175,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Paya Carlos V | President and CEO | Sell | S | 5.35 | 3,940 | 21,079 | 68,060 | 72 K to 68.1 K (-5.47 %) |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Paya Carlos V | President and CEO | Grant | A | 0.00 | 36,000 | 0 | 72,000 | 36 K to 72 K (+100.00 %) |
Jan 06 2017 | IMDZ | Immune Design Corp ... | BALTIMORE DAVID | Director | Option Exercise | A | 5.60 | 10,000 | 56,000 | 10,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Option Exercise | A | 5.60 | 10,000 | 56,000 | 10,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Kelley Susan L. | Director | Option Exercise | A | 5.60 | 10,000 | 56,000 | 10,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Option Exercise | A | 5.60 | 10,000 | 56,000 | 10,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Option Exercise | A | 5.60 | 10,000 | 56,000 | 10,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Brady Stephen R | EVP, Strategy & Fin ... | Option Exercise | A | 5.60 | 85,000 | 476,000 | 85,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Brady Stephen R | EVP, Strategy & Fin ... | Sell | S | 5.35 | 1,642 | 8,785 | 30,490 | 32.1 K to 30.5 K (-5.11 %) |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Brady Stephen R | EVP, Strategy & Fin ... | Grant | A | 0.00 | 15,000 | 0 | 32,132 | 17.1 K to 32.1 K (+87.56 %) |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Yurasov Sergey | Sr. VP, Clinic. Dev ... | Option Exercise | A | 5.60 | 30,000 | 168,000 | 30,000 | |
Jan 06 2017 | IMDZ | Immune Design Corp ... | Yurasov Sergey | Sr. VP, Clinic. Dev ... | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Jan 06 2017 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Option Exercise | A | 5.60 | 10,000 | 56,000 | 10,000 | |
Dec 27 2016 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Sell | S | 6.20 | 10,000 | 62,039 | 40,000 | 50 K to 40 K (-20.00 %) |
Dec 20 2016 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Sell | S | 6.55 | 50,000 | 327,330 | 25,000 | 75 K to 25 K (-66.67 %) |
Oct 04 2016 | IMDZ | Immune Design Corp ... | Yurasov Sergey | Sr. VP, Clinic. Dev ... | Option Exercise | A | 7.58 | 140,000 | 1,061,200 | 140,000 | |
Sep 22 2016 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Buy | P | 6.25 | 800,000 | 5,000,000 | 3,961,942 | 3.2 M to 4 M (+25.30 %) |
Sep 20 2016 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Buy | P | 6.25 | 40,000 | 250,000 | 50,000 | 10 K to 50 K (+400.00 %) |
Sep 20 2016 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Buy | P | 6.25 | 800,000 | 5,000,000 | 800,000 | 0 to 800 K |
Jul 19 2016 | IMDZ | Immune Design Corp ... | Brady Stephen R | EVP, Strategy & Fin ... | Buy | P | 6.84 | 1,500 | 10,255 | 17,132 | 15.6 K to 17.1 K (+9.60 %) |
Jun 17 2016 | IMDZ | Immune Design Corp ... | Kelley Susan L. | Director | Option Exercise | A | 10.10 | 23,300 | 235,330 | 23,300 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | ter Meulen Jan Henrik | Chief Scientific Of ... | Option Exercise | A | 19.39 | 60,000 | 1,163,400 | 60,000 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | ter Meulen Jan Henrik | Chief Scientific Of ... | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
Jan 06 2016 | IMDZ | Immune Design Corp ... | Paya Carlos V | President and CEO | Option Exercise | A | 19.39 | 175,000 | 3,393,250 | 175,000 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | Paya Carlos V | President and CEO | Grant | A | 0.00 | 36,000 | 0 | 36,000 | 0 to 36 K |
Jan 06 2016 | IMDZ | Immune Design Corp ... | Kenney Richard T | Chief Medical Offic ... | Option Exercise | A | 19.39 | 30,000 | 581,700 | 30,000 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | Kenney Richard T | Chief Medical Offic ... | Grant | A | 0.00 | 7,000 | 0 | 7,522 | 522 to 7.5 K (+1,341.00 %) |
Jan 06 2016 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Option Exercise | A | 19.39 | 60,000 | 1,163,400 | 60,000 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Grant | A | 0.00 | 12,000 | 0 | 12,034 | 34 to 12 K (+35,294.12 %) |
Jan 06 2016 | IMDZ | Immune Design Corp ... | Brady Stephen R | EVP, Strategy & Fin ... | Option Exercise | A | 19.39 | 75,000 | 1,454,250 | 75,000 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | Brady Stephen R | EVP, Strategy & Fin ... | Grant | A | 0.00 | 15,000 | 0 | 15,632 | 632 to 15.6 K (+2,373.42 %) |
Jan 06 2016 | IMDZ | Immune Design Corp ... | RINGO WILLIAM R | Director | Option Exercise | A | 19.39 | 9,300 | 180,327 | 9,300 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Option Exercise | A | 19.39 | 9,300 | 180,327 | 9,300 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Option Exercise | A | 19.39 | 9,300 | 180,327 | 9,300 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Option Exercise | A | 19.39 | 9,300 | 180,327 | 9,300 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Option Exercise | A | 19.39 | 9,300 | 180,327 | 9,300 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | BALTIMORE DAVID | Director | Option Exercise | A | 19.39 | 9,300 | 180,327 | 9,300 | |
Jan 06 2016 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Option Exercise | A | 19.39 | 9,300 | 180,327 | 9,300 | |
Nov 24 2015 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Option Exercise | M | 1.31 | 5,000 | 6,550 | 48,715 | |
Nov 24 2015 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Sell | S | 20.00 | 5,000 | 100,000 | 34 | 5 K to 34 (-99.32 %) |
Nov 24 2015 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Buy | M | 1.31 | 5,000 | 6,550 | 5,034 | 34 to 5 K (+14,705.88 %) |
Nov 03 2015 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Option Exercise | A | 13.00 | 40,000 | 520,000 | 40,000 | |
Nov 03 2015 | IMDZ | Immune Design Corp ... | ter Meulen Jan Henrik | Chief Scientific Of ... | Option Exercise | A | 13.00 | 40,000 | 520,000 | 40,000 | |
Nov 03 2015 | IMDZ | Immune Design Corp ... | Kenney Richard T | Chief Medical Offic ... | Option Exercise | A | 13.00 | 40,000 | 520,000 | 40,000 | |
Nov 03 2015 | IMDZ | Immune Design Corp ... | Brady Stephen R | EVP, Strategy & Fin ... | Option Exercise | A | 13.00 | 50,000 | 650,000 | 50,000 | |
Nov 03 2015 | IMDZ | Immune Design Corp ... | Paya Carlos V | President and CEO | Option Exercise | A | 13.00 | 90,000 | 1,170,000 | 90,000 | |
Sep 16 2015 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Option Exercise | M | 1.31 | 5,000 | 6,550 | 53,715 | |
Sep 16 2015 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Sell | S | 16.19 | 5,000 | 80,955 | 34 | 5 K to 34 (-99.32 %) |
Sep 16 2015 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Buy | M | 1.31 | 5,000 | 6,550 | 5,034 | 34 to 5 K (+14,705.88 %) |
Aug 26 2015 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Buy | P | 14.50 | 3,000 | 43,500 | 3,000 | 0 to 3 K |
May 13 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 21.50 | 155,000 | 3,332,500 | 1,983,858 | 2.1 M to 2 M (-7.25 %) |
May 13 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 22.26 | 22,607 | 503,232 | 2,138,858 | 2.2 M to 2.1 M (-1.05 %) |
Apr 24 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.64 | 25,000 | 666,000 | 2,161,465 | 2.2 M to 2.2 M (-1.14 %) |
Apr 24 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.35 | 22,643 | 619,286 | 2,186,465 | 2.2 M to 2.2 M (-1.02 %) |
Apr 24 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.64 | 10,000 | 266,400 | 2,209,108 | 2.2 M to 2.2 M (-0.45 %) |
Apr 24 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.56 | 25,249 | 670,613 | 2,219,108 | 2.2 M to 2.2 M (-1.12 %) |
Apr 21 2015 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Buy | P | 26.50 | 10,000 | 265,000 | 10,000 | 0 to 10 K |
Apr 21 2015 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Buy | P | 26.50 | 25,000 | 662,500 | 75,000 | 50 K to 75 K (+50.00 %) |
Apr 21 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.35 | 14,167 | 373,300 | 2,244,357 | 2.3 M to 2.2 M (-0.63 %) |
Apr 21 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.44 | 12,792 | 338,220 | 2,258,524 | 2.3 M to 2.3 M (-0.56 %) |
Apr 21 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.67 | 18,861 | 503,023 | 2,271,316 | 2.3 M to 2.3 M (-0.82 %) |
Apr 16 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.75 | 100 | 2,675 | 2,290,177 | 2.3 M to 2.3 M (0.00 %) |
Apr 16 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 29.17 | 100 | 2,917 | 2,290,277 | 2.3 M to 2.3 M (0.00 %) |
Apr 16 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 28.57 | 39,900 | 1,139,943 | 2,290,377 | 2.3 M to 2.3 M (-1.71 %) |
Apr 16 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.26 | 13,814 | 376,570 | 2,330,277 | 2.3 M to 2.3 M (-0.59 %) |
Apr 08 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.55 | 3,600 | 95,580 | 2,344,091 | 2.3 M to 2.3 M (-0.15 %) |
Apr 08 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.88 | 3,895 | 104,698 | 2,347,691 | 2.4 M to 2.3 M (-0.17 %) |
Apr 02 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.07 | 8,035 | 217,507 | 2,351,586 | 2.4 M to 2.4 M (-0.34 %) |
Apr 02 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.55 | 39,819 | 1,057,194 | 2,359,621 | 2.4 M to 2.4 M (-1.66 %) |
Apr 02 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.51 | 14,600 | 372,446 | 2,399,440 | 2.4 M to 2.4 M (-0.60 %) |
Mar 26 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.56 | 4,956 | 136,587 | 2,414,040 | 2.4 M to 2.4 M (-0.20 %) |
Mar 26 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.67 | 13,200 | 365,244 | 2,418,996 | 2.4 M to 2.4 M (-0.54 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.78 | 5,000 | 138,900 | 2,432,196 | 2.4 M to 2.4 M (-0.21 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 28.15 | 84 | 2,365 | 2,437,196 | 2.4 M to 2.4 M (0.00 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 28.13 | 400 | 11,252 | 2,437,280 | 2.4 M to 2.4 M (-0.02 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 28.04 | 200 | 5,608 | 2,437,680 | 2.4 M to 2.4 M (-0.01 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.19 | 8,780 | 238,749 | 2,437,880 | 2.4 M to 2.4 M (-0.36 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 28.07 | 200 | 5,614 | 2,446,660 | 2.4 M to 2.4 M (-0.01 %) |
Mar 23 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.55 | 29,800 | 820,990 | 2,446,860 | 2.5 M to 2.4 M (-1.20 %) |
Mar 19 2015 | IMDZ | Immune Design Corp ... | COLEMAN LEWIS W | Director | Option Exercise | A | 26.57 | 23,300 | 619,081 | 23,300 | |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.02 | 100 | 2,702 | 2,476,660 | 2.5 M to 2.5 M (0.00 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.99 | 500 | 13,495 | 2,476,760 | 2.5 M to 2.5 M (-0.02 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 27.04 | 100 | 2,704 | 2,477,260 | 2.5 M to 2.5 M (0.00 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 26.56 | 19,300 | 512,608 | 2,477,360 | 2.5 M to 2.5 M (-0.77 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.94 | 20,000 | 518,800 | 2,496,660 | 2.5 M to 2.5 M (-0.79 %) |
Mar 18 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.43 | 10,309 | 262,158 | 2,516,660 | 2.5 M to 2.5 M (-0.41 %) |
Mar 12 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 24.94 | 94,199 | 2,349,323 | 2,526,969 | 2.6 M to 2.5 M (-3.59 %) |
Mar 12 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.02 | 29,000 | 725,580 | 2,621,168 | 2.7 M to 2.6 M (-1.09 %) |
Mar 12 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 24.65 | 6,143 | 151,425 | 2,650,168 | 2.7 M to 2.7 M (-0.23 %) |
Mar 09 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.61 | 32,300 | 827,203 | 2,656,311 | 2.7 M to 2.7 M (-1.20 %) |
Mar 09 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.02 | 100 | 2,502 | 2,688,611 | 2.7 M to 2.7 M (0.00 %) |
Mar 09 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 25.00 | 1,046 | 26,150 | 2,688,711 | 2.7 M to 2.7 M (-0.04 %) |
Mar 09 2015 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 24.65 | 6,000 | 147,900 | 2,689,757 | 2.7 M to 2.7 M (-0.22 %) |
Jan 09 2015 | IMDZ | Immune Design Corp ... | ter Meulen Jan Henrik | Chief Scientific Of ... | Option Exercise | A | 31.00 | 25,000 | 775,000 | 25,000 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | Kenney Richard T | Chief Medical Offic ... | Option Exercise | A | 31.00 | 30,000 | 930,000 | 30,000 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | BALTIMORE DAVID | Director | Option Exercise | A | 31.00 | 9,300 | 288,300 | 9,300 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Option Exercise | A | 31.00 | 9,300 | 288,300 | 9,300 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | Gombotz Wayne | Chief Development O ... | Option Exercise | A | 31.00 | 15,000 | 465,000 | 15,000 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Option Exercise | A | 31.00 | 9,300 | 288,300 | 9,300 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Option Exercise | A | 31.00 | 9,300 | 288,300 | 9,300 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | Brady Stephen R | Chief Business Offi ... | Option Exercise | A | 31.00 | 50,000 | 1,550,000 | 50,000 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Option Exercise | A | 31.00 | 9,300 | 288,300 | 9,300 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | RINGO WILLIAM R | Director | Option Exercise | A | 31.00 | 9,300 | 288,300 | 9,300 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | Rickey James Paul | VP, Finance and Adm ... | Option Exercise | A | 31.00 | 25,000 | 775,000 | 25,000 | |
Jan 09 2015 | IMDZ | Immune Design Corp ... | Paya Carlos V | President and CEO | Option Exercise | A | 31.00 | 100,000 | 3,100,000 | 100,000 |